Stopping statins for primary prevention appears safe at two years for multimorbid adults 70 and older, but the STREAM trial’s ...
Stable coronary artery disease patients gain no survival benefit from stents or bypass surgery, a landmark 13-year trial ...
NASA Moon Base Student Challenge launches November 8, 2026, putting $1 million in prizes behind six real, unsolved ...
Stroke prevention blood pressure research reaches a landmark turn: the OPTIMAL-Stroke trial, the largest RCT ever in ischemic stroke and TIA survivors, found that a systolic target below 120 mm Hg ...
Precision BioSciences’ gene editing therapy PBGENE-HBV eliminated hepatitis B’s cccDNA viral reservoir in every evaluable ...
A five-year RCT of PulsePoint, the CPR alert app in nearly 6,000 communities, found no statistically significant benefit from ...
Vinh Long Province screened 99.99% of its 3.37 million residents for free in 90 days. All records now link to VNeID, ...
Vir Biotechnology presents Phase 3 ECLIPSE 1 trial data at AASLD 2026 today, testing once-monthly elebsiran plus tobevibart ...
Oral psoriatic arthritis treatment reached a milestone as icotrokinra (ICOTYDE) cleared its Phase 3 primary joint endpoint at 58% versus 41% for placebo, while 57% of patients achieved near-complete s ...
Air purifier blood sugar research now has human clinical trial backing: NYU Langone’s first randomized trial, presented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results